TELA Bio, Inc.
TELA
$1.95
$0.010.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.22M | 69.30M | 68.65M | 64.74M | 63.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.22M | 69.30M | 68.65M | 64.74M | 63.15M |
| Cost of Revenue | 23.17M | 22.43M | 21.38M | 19.94M | 19.22M |
| Gross Profit | 48.04M | 46.87M | 47.27M | 44.80M | 43.93M |
| SG&A Expenses | 78.47M | 79.37M | 83.04M | 81.09M | 78.82M |
| Depreciation & Amortization | 380.00K | 380.00K | 380.00K | 380.00K | 380.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 110.98M | 111.00M | 114.27M | 111.18M | 108.37M |
| Operating Income | -39.76M | -41.70M | -45.62M | -46.44M | -45.23M |
| Income Before Tax | -43.54M | -37.99M | -41.52M | -42.11M | -40.30M |
| Income Tax Expenses | -92.00K | -144.00K | -- | -- | -- |
| Earnings from Continuing Operations | -43.44 | -37.84 | -41.52 | -42.11 | -40.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.44M | -37.84M | -41.52M | -42.11M | -40.30M |
| EBIT | -39.76M | -41.70M | -45.62M | -46.44M | -45.23M |
| EBITDA | -38.72M | -40.68M | -44.71M | -45.57M | -44.40M |
| EPS Basic | -1.41 | -1.39 | -1.69 | -1.72 | -1.67 |
| Normalized Basic EPS | -0.88 | -1.06 | -1.25 | -1.26 | -1.24 |
| EPS Diluted | -1.41 | -1.39 | -1.69 | -1.72 | -1.67 |
| Normalized Diluted EPS | -0.88 | -1.06 | -1.25 | -1.26 | -1.24 |
| Average Basic Shares Outstanding | 134.71M | 114.02M | 98.44M | 98.22M | 96.79M |
| Average Diluted Shares Outstanding | 134.71M | 114.02M | 98.44M | 98.22M | 96.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |